Quantcast

ArQule Articles

Lung Cancer Drug Trial Cancelled Lung Cancer Drug Trial Cancelled
· 2

This week, ArQule, a biotechnology company focused on developing “next-generation” small-molecule cancer drugs, announced that a drug trial for a lung cancer treatment it developed has been stopped early. The independent Data Monitoring Committee (DMC) overseeing the Phase 3 trial …